Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Lacey Mouser

Physician Assistant Lawrenceburg, TN Physician Assistant

NPI 1235411257 CMS profile 10876117

2131 N Locust Ave, Lawrenceburg, TN 38464

Open in the dashboard

General payments

$5,345

109 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lacey Mouser of Lawrenceburg, TN is reported in the CMS Open Payments database as having received $5,345 across 109 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $791 27
2024 General $1,208 27
2023 General $352 19
2022 General $2,866 29
2021 General $128 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lacey Mouser
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Lacey Mouser were reported at $791. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Lacey Mouser Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $128 $132 $37–$438 $132
2022 $2,866 $155 $48–$522 $149
2023 $352 $167 $52–$557 $160
2024 $1,208 $178 $55–$600 $164
2025 $791 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Merz North America, Inc. $3,236 25 payments
  2. Revance Therapeutics, Inc. $661 22 payments
  3. Allergan Inc. $457 23 payments
  4. AbbVie, Inc. $441 28 payments
  5. Galderma Laboratories, L.P. $400 7 payments
  6. Sientra, Inc. $114 2 payments
  7. Pacira Pharmaceuticals Incorporated $36 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,683 107 payments
  2. Travel and Lodging $1,662 2 payments
Products named General payments · program years 2021–2025
  1. Xeomin $2,522 10 payments
  2. DAXXIFY $661 22 payments
  3. BOTOX $231 16 payments
  4. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $114 2 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $112 6 payments
  6. DYSPORT $107 1 payment
  7. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $49 3 payments
  8. Exparel $36 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

109 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record